Jane Street’s Amneal Pharmaceuticals AMRX Stock Holding History

Jane Street’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Buy	+13,500	New	+$185K	﹤0.01%	9754
2026 Q1	–	Sell	-32,000	Closed	-$403K	–	11480
2025 Q4	$403K	Hold	32,000	–	–	﹤0.01%	8176
2025 Q3	$320K	Buy	+32,000	New	+$287K	﹤0.01%	8770
2025 Q2	–	Sell	-89,000	Closed	-$746K	–	9537
2025 Q1	$746K	Buy	+89,000	New	+$743K	﹤0.01%	6115
2024 Q2	–	Sell	-15,100	Closed	-$91.5K	–	9282
2024 Q1	$91.5K	Buy	+15,100	New	+$85.1K	﹤0.01%	8559
2022 Q1	–	Sell	-38,500	Closed	-$184K	–	10214
2021 Q4	$184K	Sell	38,500 -1,700	-4%	-$8.47K	﹤0.01%	8875
2021 Q3	$215K	Buy	+40,200	New	+$202K	﹤0.01%	8739
2021 Q2	–	Sell	-16,100	Closed	-$108K	–	9716
2021 Q1	$108K	Buy	+16,100	New	+$89.2K	﹤0.01%	8609

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Jane Street's AMRX Position: Q1 2026 in Review

Jane Street sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 975,525 shares — an estimated $13.1M sold.

Jane Street first reported a position in AMRX in Q3 2018 and held it in 18 quarters. The position peaked at $12.3M in Q4 2025. 317 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Jane Street reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Jane Street sold 975,525 Amneal Pharmaceuticals shares in Q1 2026, an estimated $13.1M.
Jane Street first reported a position in Amneal Pharmaceuticals in Q3 2018 and held it in 18 quarters.
Jane Street's Amneal Pharmaceuticals position peaked at $12.3M in Q4 2025.
317 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.